Siblings Conference Papers/Meeting Abstract [7/11] Collection Statistics Item counts issued in 3 years:0(0.00%) Items With Fulltext:19(95.00%) Download counts of the item Download times greater than 0:19(100.00%) Download times greater than 100:19(100.00%) Total Bitstream Download Counts:19115(80.75%) Last Update: 2024-12-11 16:46 Top Upload Loading... Top Download Loading... Recent Submissions A phase I dose escalation study of ... Randomised clinical trial: Comparis... Combination of arsenic trioxide and... Novel feedback inhibition of surfac... Clinical and biological implication... Abrogation of skin disease in lupus... D-501036, a novel selenophene-based... Alpha-fetoprotein response in advan... Phase II study of biweekly gemcitab... Phase II and pharmacokinetic study ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 20. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2017-05	A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy	Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
2013-01	Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma	Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73.
2011-12-15	Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors	Free Radical Biology and Medicine. 2011 Dec 15;51(12):2195-2209.
2011-10	Novel feedback inhibition of surface antigen synthesis by Mammalian Target of Rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy	Hepatology. 2011 Oct;54(4):1199-1207.
2009-12	Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent	Journal of Clinical Oncology. 2009 Dec;27(36):e271.
2009-11	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179.
2007-11-15	Tamoxifen accelerates proteasomal degradation of O-6-methylguanine DNA methyltransferase in human cancer cells	International Journal of Cancer. 2007 Nov;121(10):2293-2300.
2007-03-01	Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036	Biochemical Pharmacology. 2007 Mar;73(5):610-619.
2007-01	D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation	Molecular Cancer Therapeutics. 2007 Jan;6(1):193-202.
2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.

Showing items 1-10 of 20. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page